ITMI910843A0 - Medicamento contenente "diidroergocriptina ad azione neuroprotettrice - Google Patents

Medicamento contenente "diidroergocriptina ad azione neuroprotettrice

Info

Publication number
ITMI910843A0
ITMI910843A0 IT91MI843A ITMI910843A ITMI910843A0 IT MI910843 A0 ITMI910843 A0 IT MI910843A0 IT 91MI843 A IT91MI843 A IT 91MI843A IT MI910843 A ITMI910843 A IT MI910843A IT MI910843 A0 ITMI910843 A0 IT MI910843A0
Authority
IT
Italy
Prior art keywords
dihydroergocriptine
product containing
medicinal product
neuroprotective action
neuroprotective
Prior art date
Application number
IT91MI843A
Other languages
English (en)
Inventor
Stefano Poli
Federico Mailland
Germano Coppi
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Publication of ITMI910843A0 publication Critical patent/ITMI910843A0/it
Priority to ITMI910843A priority Critical patent/IT1245369B/it
Priority to AT91116311T priority patent/ATE183093T1/de
Priority to EP91116311A priority patent/EP0505608B1/en
Priority to DE69131521T priority patent/DE69131521T2/de
Priority to DK91116311T priority patent/DK0505608T3/da
Priority to DE199191116311T priority patent/DE505608T1/de
Priority to ES91116311T priority patent/ES2052467T1/es
Priority to JP3249414A priority patent/JPH04312590A/ja
Priority to CA002064112A priority patent/CA2064112C/en
Priority to KR1019920004973A priority patent/KR100196445B1/ko
Publication of ITMI910843A1 publication Critical patent/ITMI910843A1/it
Priority to GR920300126T priority patent/GR920300126T1/el
Application granted granted Critical
Publication of IT1245369B publication Critical patent/IT1245369B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ITMI910843A 1991-03-28 1991-03-28 Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice IT1245369B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITMI910843A IT1245369B (it) 1991-03-28 1991-03-28 Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice
ES91116311T ES2052467T1 (es) 1991-03-28 1991-09-25 Preparaciones farmaceuticas de alfa-dihidroergocriptina con actividad neuroprotectora.
EP91116311A EP0505608B1 (en) 1991-03-28 1991-09-25 Alpha-dihydroergocryptine pharmaceutical preparations with neuroprotective acitivity
DE69131521T DE69131521T2 (de) 1991-03-28 1991-09-25 Alpha-Ergocryptine enthaltende pharmazeutische Zusammensetzungen mit nervenschützender Wirkung
DK91116311T DK0505608T3 (da) 1991-03-28 1991-09-25 Farmaceutiske alfa-dihydroergocryptinpræparater med neurobeskyttende virkning
DE199191116311T DE505608T1 (de) 1991-03-28 1991-09-25 Alpha-ergocryptine enthaltende pharmazeutische zusammensetzungen mit nervenschuetzender wirkung.
AT91116311T ATE183093T1 (de) 1991-03-28 1991-09-25 Alpha-ergocryptine enthaltende pharmazeutische zusammensetzungen mit nervenschützender wirkung
JP3249414A JPH04312590A (ja) 1991-03-28 1991-09-27 神経防護性α−ジヒドロエルゴクリプチン医薬製剤
CA002064112A CA2064112C (en) 1991-03-28 1992-03-26 .alpha.-dihydroergocryptine pharmaceutical preparations with neuroprotective activity
KR1019920004973A KR100196445B1 (ko) 1991-03-28 1992-03-26 신경보호활성을 갖는 알파-디하이드로에르고크립틴 약제학적 제제
GR920300126T GR920300126T1 (it) 1991-03-28 1993-03-16

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910843A IT1245369B (it) 1991-03-28 1991-03-28 Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice

Publications (3)

Publication Number Publication Date
ITMI910843A0 true ITMI910843A0 (it) 1991-03-28
ITMI910843A1 ITMI910843A1 (it) 1992-09-28
IT1245369B IT1245369B (it) 1994-09-20

Family

ID=11359300

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910843A IT1245369B (it) 1991-03-28 1991-03-28 Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice

Country Status (10)

Country Link
EP (1) EP0505608B1 (it)
JP (1) JPH04312590A (it)
KR (1) KR100196445B1 (it)
AT (1) ATE183093T1 (it)
CA (1) CA2064112C (it)
DE (2) DE505608T1 (it)
DK (1) DK0505608T3 (it)
ES (1) ES2052467T1 (it)
GR (1) GR920300126T1 (it)
IT (1) IT1245369B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041855A1 (it) * 2004-09-29 2004-12-29 Polichem Sa Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200603B (it) * 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutiche ad attivita dopaminergica

Also Published As

Publication number Publication date
DE69131521D1 (de) 1999-09-16
DE505608T1 (de) 1993-03-18
EP0505608A3 (en) 1993-02-03
DE69131521T2 (de) 2000-03-30
ITMI910843A1 (it) 1992-09-28
ES2052467T1 (es) 1994-07-16
KR920017652A (ko) 1992-10-21
IT1245369B (it) 1994-09-20
KR100196445B1 (ko) 1999-06-15
DK0505608T3 (da) 2000-03-20
ATE183093T1 (de) 1999-08-15
JPH04312590A (ja) 1992-11-04
CA2064112C (en) 2002-12-31
CA2064112A1 (en) 1992-09-29
EP0505608A2 (en) 1992-09-30
GR920300126T1 (it) 1993-03-16
EP0505608B1 (en) 1999-08-11

Similar Documents

Publication Publication Date Title
FI942993A (fi) Organoaluminoksituote ja sen käyttö
ATE136736T1 (de) Süsswarenprodukt
DE69302958D1 (de) Medizinbeutel
ITRM920237A1 (it) Perfezionato impiego di medicinali broncodilatatori b2.
ATA118390A (de) Produktabgabeeinrichtung
DE69218727T2 (de) Medikamentenbehälter
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
BR9200875A (pt) Produto de adicao e composicao de oxigenio
DK86492D0 (da) Laegemiddel
DE69231387T2 (de) Spezialisierter Produktbeutel
FI921962A (fi) Foerfarande foer blekning av cellulosahaltiga material
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
ITMI910843A0 (it) Medicamento contenente "diidroergocriptina ad azione neuroprotettrice
ITMI912652A0 (it) Medicamento ad attivita' antielasica
FI921961A (fi) Foerfarande foer blekning av xylan- och lignocellulosahaltiga material
DE69212780D1 (de) Selbstmetabolisierendes funktionelles Material
FI933456A (fi) Material bestaoende av kolfoereningar
FI923967A (fi) Foerfarande foer framstaellning av formpressade material
FI915230A (fi) Foerfarande foer malning av finfoerdelat material
FI921756A (fi) Foerfarande foer framstaellning av 4'-demetylepipodofyllotoxin glukosid 4'-fosfater
DE69216929T2 (de) "Flip-Chart"
SE9102577D0 (sv) Laekemedel med antidopamineffekt
SE9003275D0 (sv) Laekemedel med antidopamineffekt
SE9000231D0 (sv) Laekemedel med antidopamineffekt
UA25976C2 (uk) Противиразковий лікарський препарат

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970326